RVV — Revive Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Revive Therapeutics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.475	1.48	16.6	3.92	2.09
Net Total Receivables	—	0.178	0.127	0.191	0.157
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.528	2.16	16.8	4.16	2.35
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.004	0.003	0.002	0.002	0.001
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	1.28	8.26	29.8	17.1	14.3
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.322	0.372	0.598	4.17	3.44
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.322	0.832	1	4.46	3.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.961	7.43	28.8	12.6	10.7
Total Liabilities & Shareholders' Equity	1.28	8.26	29.8	17.1	14.3
Total Common Shares Outstanding